Barys Resources is seeking up to A$2.64 million through a 1-for-1 entitlement offer priced at a 41% discount, with most proceeds earmarked for Kazakhstan gold exploration. But only A$800,000 is underwritten, leaving the final funding outcome and potential dilution dependent on shareholder participation.
- A$2.64 million maximum raise at A$0.01 a share
- 1-for-1 renounceable offer at a 41% discount to the last close
- A$2.2 million allocated to Kazakhstan exploration
- Mahe Capital underwriting covers A$800,000
- Shares on issue could double to 528.1 million
Barys Resources Limited (ASX:BRY) is asking shareholders to double down on its Kazakhstan gold strategy, launching a 1-for-1 renounceable entitlement offer that could raise up to A$2.64 million before costs. The offer price of A$0.01 is a 41% discount to Barys’ A$0.017 closing price on 11 September, and a 37% discount to the 30-day VWAP cited in the company’s announcement.
Kazakhstan Exploration Takes the Lion’s Share
Of the proposed proceeds, A$2.2 million is allocated to exploration on Barys’ existing Dalnee and Karakul tenements in the Balkash region. A further A$50,000 is earmarked for project generation and A$50,000 for new project acquisition and exploration, with the company indicating a gold focus for potential Central Asian opportunities.
The balance of the budget allows A$150,000 for corporate costs, A$28,320 for other working capital and an estimated A$162,019 for the offer itself. Barys says exploration activity will be scaled back if the raising is not fully subscribed, making participation levels more than a technical detail: they will determine how much of the proposed programme can proceed.
Partial Underwriting Leaves Funding Uncertain
Mahe Capital has agreed to partially underwrite A$800,000, representing 80 million new shares. That provides a floor of sorts, but not a guarantee that Barys will secure the full A$2.64 million. Any shortfall can be allocated to eligible shareholders, sophisticated or professional investors and, subject to the underwriting agreement, Mahe Capital.
If fully subscribed, the offer would add up to 264,033,878 shares to Barys’ existing 264,033,878 shares, taking total shares on issue to about 528.1 million. Shareholders who do not participate could see their percentage interest roughly halve under that maximum scenario. The offer is renounceable, so rights can be traded, although the prospectus cautions there may be no liquid market for them.
Director Non-Participation and Niger Risk
Jiandong He, Barys’ only director who holds shares, has confirmed he does not intend to take up his 49.75 million-share entitlement. That decision does not determine the result, but it means a substantial existing holder is not committing additional capital under the offer.
The prospectus also places the Kazakhstan campaign alongside a more unsettled African portfolio. Barys says it has adjusted operations in Niger after a coup attempt on 28 and 29 August 2026 and is assessing whether its Niger tenements remain viable, including the possibility of relinquishment. The company’s stated near-term funding priority is Kazakhstan, but the Niger review remains a live sovereign-risk issue for the broader portfolio.
Offer Terms Put Participation in Focus
Rights trading is scheduled to begin on 17 September, with the offer due to close on 7 October 2026. Results and the issue of new shares are expected on 14 October, subject to the indicative timetable changing. Barys has also offered Mahe Capital five options for every dollar raised, exercisable at A$0.04 and expiring on 24 October 2029.
The raise gives Barys a defined exploration budget, but it does not remove the risks the company itself identifies: exploration may not produce an economic discovery, Barys is loss-making and further capital could be required before any production. The immediate test is whether shareholders fund the Kazakhstan ambition at a price that is attractive to new money but potentially consequential for existing holders who sit out.
Bottom Line?
The offer can materially extend Barys’ Kazakhstan exploration runway, but the investment case now turns on take-up, the size of any shortfall and whether exploration converts capital into credible discoveries.
Questions in the middle?
- How much of the A$2.64 million target will shareholders actually fund by the 7 October closing date?
- Will Mahe Capital ultimately receive shares that lift its voting power, or will shortfall allocations limit that outcome?
- Can the Dalnee and Karakul programmes produce exploration results strong enough to justify further funding?